We established that concurrent suppression of SPRY1 and SPRY2 may have additional effects in decreasing EMT markers or EMT-inducing transcription factors and thus favoring epithelial phenotype in colon cancer cells. Here, SPRY1 is linked to malignant colon neoplasm.